IL18 and prostate cancer: Since inflammasome assembly is considered a master regulator of inflammation, determining the molecular function of NLRP12 as an upstream regulator of NF-κB, IL-1β, and IL-18 signaling will add to our understanding the molecular basis of inflammation induced prostate cancer.